市场调查报告书
商品编码
1521230
2024-2032 年按产品类型(传统注射器、安全注射器)、应用(免疫注射、治疗注射)、最终用户(医院、诊断实验室等)和地区分類的一次性注射器市场报告Disposable Syringes Market Report by Product Type (Conventional Syringes, Safety Syringes), Application (Immunization Injections, Therapeutic Injections), End User (Hospitals, Diagnostic Laboratories, and Others), and Region 2024-2032 |
IMARC Group年,全球一次性注射器市场规模达151亿美元。
一次性注射器广泛用于透过静脉或肌肉注射药物来治疗不同的疾病。它们是一种塑胶注射器,专为医疗、兽医和研发 (R&D) 领域的一次性使用而设计。与传统注射器相比,它们更便宜,而且没有任何维护成本。它们有助于维护患者的安全,同时减少交叉污染的机会。
目前,越来越多的人使用一次性注射器来支持各种慢性疾病的诊断和治疗,例如心臟病、癌症、中风、呼吸系统疾病、损伤、糖尿病、阿兹海默症、流感和肺炎。这加上全球手术数量的增加,是推动市场的关键因素之一。此外,由于无保护的性接触和接触受感染的血液,世界各地患有后天免疫缺乏症候群(爱滋病)的患者人数增加。再加上蓬勃发展的医疗保健产业,正在推动市场的成长。除此之外,主要市场参与者正在关注高效的消毒手术,同时避免医疗保健从业者和患者之间的感染,特别是在冠状病毒疾病(COVID-19)大流行爆发之后。此外,患者中针刺伤发生率的不断上升也刺激了对一次性注射器的需求。除此之外,自我注射药物的上升趋势也为产业投资者提供了利润丰厚的成长机会。除此之外,一些国家的政府正在采取倡议,鼓励使用一次性医疗用品,以防止手术室感染的传播。这些倡议预计将在未来几年促进市场的成长。
The global disposable syringes market size reached US$ 15.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032.
Disposable syringes are widely utilized for injecting medicines through intravenous or intramuscular ways to treat different diseases. They are plastic syringes designed for one-time use in the medical, veterinary, and research and development (R&D) fields. They are cheaper compared to traditional syringes without any maintenance costs. They assist in maintaining the safety of the patients while reducing the chances of cross-contamination.
At present, there is a rise in the use of disposable syringes to support the diagnosis and treatment of various chronic diseases, such as heart disease, cancer, stroke, respiratory disease, injuries, diabetes, Alzheimer's disease, influenza, and pneumonia. This, along with the growing number of surgeries across the globe, represents one of the key factors driving the market. In addition, there is an increase in the number of patients suffering from acquired immune deficiency syndrome (AIDS) around the world due to unprotected sexual contact and contact with infected blood. This, coupled with the burgeoning healthcare industry, is propelling the growth of the market. Besides this, key market players are focusing on efficient sterilizing surgery while avoiding infections among healthcare practitioners and patients, especially after the outbreak of the coronavirus disease (COVID-19) pandemic. Moreover, the growing incidences of needlestick injuries among patients are catalyzing the demand for disposable syringes. Besides this, the rising trend of self-injecting medicines is offering lucrative growth opportunities to industry investors. Apart from this, governments of several countries are undertaking initiatives to encourage the adoption of disposable medical supplies for preventing the spread of infections in operating rooms. These initiatives are projected to bolster the growth of the market in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global disposable syringes market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, application, and end user.
Conventional Syringes
Safety Syringes
Retractable Safety Syringes
Non-Retractable Safety Syringes
Immunization Injections
Therapeutic Injections
Hospitals
Diagnostic Laboratories
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Cardinal Health Inc., Fresenius SE & Co. KGaA, Henke-Sass Wolf GmbH, Nipro Corporation, Novo Nordisk A/S, Retractable Technologies Inc., Terumo Corporation and Vita Needle Company.